Tandem Diabetes (TNDM) Misses Q1 EPS by 8c, Revenues Beat; Provides 2Q Revenue Outlook, Withdraws FY20 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to Tandem Diabetes (TNDM) Misses Q1 EPS by 8c, Revenues Beat; Provides 2Q Revenue Outlook, Withdraws FY20 Guidance

Tandem Diabetes Care Announces First Quarter 2020 Financial Results

April 30, 2020 4:05 PM EDT

Second Quarter 2020 Sales Guidance Provided, Annual Guidance Withdrawn

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2020. In addition, due to the unknown depth and duration of the COVID-19 pandemic, the Company provided sales guidance for the second quarter 2020 and has withdrawn its financial guidance for the year ending December 31, 2020.

First Quarter 2020 Highlights

In comparing the first quarter of 2020 to the same period of 2019:

Worldwide pump... More